<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04010682</url>
  </required_header>
  <id_info>
    <org_study_id>PROTOCOL-1095</org_study_id>
    <nct_id>NCT04010682</nct_id>
  </id_info>
  <brief_title>Late Pregnancy Sample Collection Study</brief_title>
  <official_title>Late Pregnancy Sample Collection Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SPD Development Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SPD Development Company Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will obtain daily urine samples from pregnant volunteers, from 36 weeks pregnant&#xD;
      until birth. All urine samples will be stored and used for research or product validation&#xD;
      purposes.&#xD;
&#xD;
      The study will also gather information from volunteers regarding a woman's health during her&#xD;
      pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will obtain daily urine samples from pregnant volunteers, from 36 weeks pregnant&#xD;
      until birth. It is anticipated 20-40 pregnant women will be recruited to the study.&#xD;
&#xD;
      Urine samples will be delivered to SPD either via post, or by hand and form part of the SPD&#xD;
      BioBank. All urine samples will be stored and used for research or product validation&#xD;
      purposes.&#xD;
&#xD;
      The study will also gather information from volunteers regarding a woman's health during her&#xD;
      pregnancy, including any bleeding, discharge, discomfort, contractions/ Braxton Hicks via the&#xD;
      use of a daily diary.&#xD;
&#xD;
      Pregnancy outcome details including labour specifics and birth outcomes such as birth date,&#xD;
      weight, and sex of the baby will be obtained 4-6 weeks after the volunteer has given birth&#xD;
      via email correspondence between the volunteer and study co-ordinator.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    sufficient volunteer recruited for the moment. Study may be re-opened at a later date&#xD;
  </why_stopped>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>late pregnancy urine samples</measure>
    <time_frame>4 weeks</time_frame>
    <description>Number of volunteers providing daily urine samples from 36 weeks pregnant until birth.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy complications</measure>
    <time_frame>6 weeks</time_frame>
    <description>Number of participants reporting pregnancy complications from week 36 of pregnancy until birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Live birth</measure>
    <time_frame>6 weeks</time_frame>
    <description>number of study participants who's pregnancy resulted in a live birth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spontaneous vaginal delivery</measure>
    <time_frame>6 weeks</time_frame>
    <description>number of study participants who's pregnancy resulted in a spontaneous vaginal delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight of baby</measure>
    <time_frame>6 weeks</time_frame>
    <description>weight of baby in pounds and ounces or kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>multiple births</measure>
    <time_frame>6 weeks</time_frame>
    <description>number of pregnancies resulting in single baby, twins or triplets.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>urine sample collection</intervention_name>
    <description>no drug/devise intervention. sample collection study only</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Daily urine samples collected&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        healthy pregnant volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant female in 3rd trimester of pregnancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prescribed bed-rest during third trimester or any other pregnancy&#xD;
&#xD;
          -  complication that would affect the ability to participate in the study&#xD;
&#xD;
          -  more than 38 weeks pregnant&#xD;
&#xD;
          -  Have a planned caesarean section&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Johnson</last_name>
    <role>Study Director</role>
    <affiliation>SPD Development company Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>SPD Development Company Ltd</name>
      <address>
        <city>Bedford</city>
        <state>Bedfordshire</state>
        <zip>MK44 3UP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 19, 2019</study_first_submitted>
  <study_first_submitted_qc>July 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2019</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

